Skip to content
★ Sign in to follow
MK

Manohar K. Raheja

Executive
Insider activity · 24 months2 buys0 salesCumulative net flow
Total declarations
9
Company
1
▲ Purchases (6 ops.)
€104k
▼ Sales (0 ops.)
—

Latest filing published 21 May 2025 for Sight Sciences, Inc., €34k.

Filing timeline

BuySale
Manohar K. Raheja

Insider track record

Disclosed buys
6
Disclosed sells
0
Signal history

Closed purchases

Market purchases
4
Positive at T+90
0%
Median T+90
-35.0%

Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 09 Dec 2024 · 699 days ago · €18k
    +116.4%
    Entry US$3.91 · Close at T+365 US$8.46
  • Filed 05 Dec 2024 · 703 days ago · €13k
    +120.4%
    Entry US$3.87 · Close at T+365 US$8.53
  • Filed 03 Dec 2024 · 705 days ago · €17k
    +121.8%
    Entry US$3.76 · Close at T+365 US$8.34
  • Filed 21 Nov 2024 · 717 days ago · €6,984
    +86.8%
    Entry US$4.01 · Close at T+365 US$7.49

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Manohar K. Raheja: trading record in brief

Manohar K. Raheja appears in our data through filings on Sight Sciences, Inc. shares, published by SEC (Form 4). In total, 9 filings cover trades dated from 12 November 2024 to 16 May 2025.

Purchases make up the whole of the open-market record (6 purchases, €104k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 3 share grants. So far in 2025, the count stands at 2 purchases and no sales.

The median purchase comes to €18k. None of the 6 purchases we analysed coincided with buying by another insider of the same company within 30 days. After 4 purchases with a full 90-day history, the hit rate stands at 0% and the median 90-day move at -35.0%. These figures describe past trades and do not predict future prices.

The latest filing, published on 21 May 2025, reports a share grant of €34k in Sight Sciences, Inc. The clock since the last published purchase (13 March 2025) now reads 605 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Manohar K. Raheja

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations7 total
  • ◆
    EVP, Research & DevelopmentExecutivesSight Sciences, Inc.
    38,531 USD18SEC
    12,767 shares@ US$3.0186.8% of flowCommon StockSEC:0000950170-25-075990:0
  • ◆
    EVP, Research & DevelopmentExecutivesSight Sciences, Inc.
    0SEC
    24,000 shares0Common StockSEC:0000950170-25-039073:0
  • ▲
    EVP, Research & DevelopmentExecutivesSight Sciences, Inc.
    19,250 USD17SEC
    5,000 shares@ US$3.853.6% of flowCommon StockSEC:0000950170-24-134670:0
    Canonical exit: 6 Mar 2025 (T+90)
  • ▲
    EVP, Research & DevelopmentExecutivesSight Sciences, Inc.
    13,133 USD15SEC
    3,376 shares@ US$3.892.5% of flowCommon StockSEC:0000950170-24-133809:0
    Canonical exit: 3 Mar 2025 (T+90)
  • ▲
    EVP, Research & DevelopmentExecutivesSight Sciences, Inc.
    18,441 USD13SEC
    4,624 shares@ US$3.9883.5% of flowCommon StockSEC:0000950170-24-132978:0
    Canonical exit: 27 Feb 2025 (T+90)
  • ▲
    EVP, Research & DevelopmentExecutivesSight Sciences, Inc.
    7,400 USD11SEC
    2,000 shares@ US$3.701.4% of flowCommon StockSEC:0000950170-24-129888:0
    Canonical exit: 17 Feb 2025 (T+90)
  • ◆
    EVP, Research & DevelopmentExecutivesSight Sciences, Inc.
    440,640 USD19SEC
    96,000 shares@ US$4.5982.2% of flowCommon StockSEC:0000950170-24-128221:0

7 of 7 declarations